HUTCHMED (China) (HCM) Receivables - Other (2014 - 2025)
HUTCHMED (China)'s (HCM) quarterly Receivables - Other came in at $21.5 million in Q2 2025, up 46.11% year-on-year from $14.7 million in Q2 2024, and up 46.11% on a QoQ basis from $14.7 million in Q2 2024.
HUTCHMED (China) (HCM) Receivables - Other (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 12 years of Receivables - Other data on file, last reported at $21.5 million in Q2 2025.
- On a quarterly basis, Receivables - Other rose 46.11% year-over-year to $21.5 million in Q2 2025; TTM through Jun 2025 was $21.5 million, a 46.11% increase from a year earlier, with the FY2025 full-year figure at $51.8 million, up 555.73% from the prior year.
- Receivables - Other for Q2 2025 stood at $21.5 million, up from $14.7 million in the prior quarter.
- Over the last five years, Receivables - Other for HCM reached as high as $73.0 million in Q2 2022 and fell as low as $14.7 million in Q2 2024.
- Historically, Receivables - Other has averaged $34.1 million across 5 years, with a median of $29.3 million in 2023.
- Across the five-year window, Receivables - Other jumped 127.39% in 2022 and tumbled 59.91% in 2023, its largest moves.
- Year by year, Receivables - Other stood at $32.1 million in 2021, then soared by 127.39% to $73.0 million in 2022, then tumbled by 59.91% to $29.3 million in 2023, then plunged by 49.75% to $14.7 million in 2024, then surged by 46.11% to $21.5 million in 2025.
- Per Business Quant data, the three most recent Receivables - Other figures were $21.5 million in Q2 2025, $14.7 million in Q2 2024, and $29.3 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 21.50 Mn |
| Jun 30, 2025 | 21.50 Mn |
| Jun 30, 2024 | 14.71 Mn |
| Jun 30, 2024 | 14.71 Mn |
| Jun 30, 2023 | 29.28 Mn |
| Jun 30, 2023 | 29.28 Mn |
| Jun 30, 2022 | 73.03 Mn |
| Jun 30, 2022 | 73.03 Mn |
| Jun 30, 2021 | 32.12 Mn |
| Jun 30, 2021 | 32.12 Mn |
| Dec 31, 2020 | 27.93 Mn |
| Dec 31, 2020 | 27.93 Mn |
| Jun 30, 2020 | 17.50 Mn |
| Jun 30, 2020 | 17.50 Mn |
| Dec 31, 2019 | 15.77 Mn |
| Dec 31, 2019 | 15.77 Mn |
| Dec 31, 2018 | 27,000.00 |
| Dec 31, 2018 | 27,000.00 |
| Jun 30, 2018 | 14.32 Mn |
| Jun 30, 2018 | 14.32 Mn |